| Woodsprings Pharmacy | |
| 1807 Woodsprings Rd, Jonesboro, Arkansas 72401 | |
| (870) 972-8310 |
| Name | Woodsprings Pharmacy |
|---|---|
| Organization Name | Bari Inc |
| Location | 1807 Woodsprings Rd, Jonesboro, Arkansas 72401 |
| Type | Pharmacy |
| Phone | (870) 972-8310 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
An article published in the May 2010 edition of Postgraduate Medicine documents a case study where a previously healthy, 15-week-old male infant was misdiagnosed and died of meningococcal disease. Initially the patient showed signs of the common cold and was treated as such, but symptoms worsened and he was admitted to the hospital emergency department.
Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.
The after effects of the terror attacks on 11th September 2001 in the United States are still appearing. Around 15 men who were present near the Ground Zero on the fateful day have been diagnosed with rare forms of male breast cancer. Male breast cancer makes up for less than 1 percent of all breast cancers.
Biogen Idec announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a single demyelinating event.
› Verified 1 days ago
| NPI Number | 1184115040 |
| Organization Name | BARI INC |
| Doing Business As | WOODSPRINGS PHARMACY LONG-TERM CARE |
| Type | Pharmacy |
| Address | 1807 Woodsprings Rd, Jonesboro, AR 72401 |
| Phone Number | 870-972-8310 |
News Archive
An article published in the May 2010 edition of Postgraduate Medicine documents a case study where a previously healthy, 15-week-old male infant was misdiagnosed and died of meningococcal disease. Initially the patient showed signs of the common cold and was treated as such, but symptoms worsened and he was admitted to the hospital emergency department.
Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.
The after effects of the terror attacks on 11th September 2001 in the United States are still appearing. Around 15 men who were present near the Ground Zero on the fateful day have been diagnosed with rare forms of male breast cancer. Male breast cancer makes up for less than 1 percent of all breast cancers.
Biogen Idec announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a single demyelinating event.
› Verified 1 days ago
| NPI Number | 1902803042 |
| Organization Name | BARI INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1807 Woodsprings Rd, Jonesboro, AR 72401 |
| Phone Number | 870-972-8310 |
News Archive
An article published in the May 2010 edition of Postgraduate Medicine documents a case study where a previously healthy, 15-week-old male infant was misdiagnosed and died of meningococcal disease. Initially the patient showed signs of the common cold and was treated as such, but symptoms worsened and he was admitted to the hospital emergency department.
Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.
The after effects of the terror attacks on 11th September 2001 in the United States are still appearing. Around 15 men who were present near the Ground Zero on the fateful day have been diagnosed with rare forms of male breast cancer. Male breast cancer makes up for less than 1 percent of all breast cancers.
Biogen Idec announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a single demyelinating event.
› Verified 1 days ago
News Archive
An article published in the May 2010 edition of Postgraduate Medicine documents a case study where a previously healthy, 15-week-old male infant was misdiagnosed and died of meningococcal disease. Initially the patient showed signs of the common cold and was treated as such, but symptoms worsened and he was admitted to the hospital emergency department.
Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.
The after effects of the terror attacks on 11th September 2001 in the United States are still appearing. Around 15 men who were present near the Ground Zero on the fateful day have been diagnosed with rare forms of male breast cancer. Male breast cancer makes up for less than 1 percent of all breast cancers.
Biogen Idec announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a single demyelinating event.
› Verified 1 days ago
Affordable Medical Type: DME Supplier - Oxygen Equipment & Supplies Location: 4707 E Johnson Ave, Jonesboro, Arkansas 72401 Phone: (870) 972-5900 | |
Cvs Pharmacy #10666 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 110 Southwest Dr, Jonesboro, Arkansas 72401 Phone: (870) 268-1743 | |
Cvs Pharmacy #17037 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3000 E Highland Dr Ste A, Jonesboro, Arkansas 72401 Phone: (870) 934-9668 | |
Woodsprings Pharmacy Type: Pharmacy Location: 1807 Woodsprings Rd, Jonesboro, Arkansas 72401 Phone: (870) 972-8310 | |
Jonesboro Prosthetic & Orthotic Lab Type: Prosthetic/Orthotic Supplier Location: 820 Professional Acres Dr, Jonesboro, Arkansas 72401 Phone: (870) 932-6436 |